Hysterectomy and risk of cardiovascular disease: a population-based cohort study

Erik Ingelsson1, Cecilia Lundholm, Anna L V Johansson

  • 1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Box 281, SE-171 77 Stockholm, Sweden.

European Heart Journal
|December 28, 2010
PubMed

Insights

Hysterectomy before age 50 significantly increases cardiovascular disease (CVD) risk. Oophorectomy alongside hysterectomy further elevates risks for coronary heart disease and stroke in younger women.

Area of Science:

  • Reproductive Medicine
  • Cardiovascular Health
  • Surgical Outcomes

Background:

  • Hysterectomy is a common surgical procedure for benign conditions in women.
  • The long-term cardiovascular disease (CVD) risk following hysterectomy is not fully understood.

Purpose of the Study:

  • To investigate the association between hysterectomy, with or without oophorectomy, and the risk of developing CVD later in life.

Main Methods:

  • Population-based cohort study utilizing nationwide Swedish healthcare registers.
  • Included 184,441 women who underwent hysterectomy for benign indications (1973-2003) and 640,043 controls.
  • Main outcome: first hospitalization or death from incident CVD (coronary heart disease, stroke, heart failure).

Main Results:

  • In women under 50 at study entry, hysterectomy was linked to a significantly increased CVD risk (HR 1.18).
  • Oophorectomy before or at the time of hysterectomy further elevated CVD risk (HR 2.22 without oophorectomy, HR 1.25 with oophorectomy).
  • No significant association between hysterectomy and CVD risk was observed in women aged 50 or above.

Conclusions:

  • Hysterectomy performed in women aged 50 or younger substantially increases the risk of future cardiovascular disease.
  • Concurrent oophorectomy exacerbates the risk of coronary heart disease and stroke in this age group.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...